Implitapide in Patients With Hypertriglyceridemia (HTG) on Maximal, Concurrent Triglyceride-Lowering Therapy
Status:
Terminated
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if implitapide is effective in lowering
triglyceride (TG) levels in patients with Fredrickson Type I or V hypertriglyceridemia where
the maximum tolerable medication and diet were not sufficient.